108 related articles for article (PubMed ID: 7059368)
1. Preferential incorporation of sangivamycin into ribonucleic acid in Sarcoma 180 cells in vitro.
Ritch PS; Glazer RI
Biochem Pharmacol; 1982 Jan; 31(2):259-61. PubMed ID: 7059368
[No Abstract] [Full Text] [Related]
2. Comparison between the inhibitory activities of sangivamycin and thiosangivamycin on nuclear ribonucleic acid synthesis in L1210 cells in vitro.
Glazer RI; Peale AL
Biochem Pharmacol; 1980 Feb; 29(3):305-10. PubMed ID: 7362643
[No Abstract] [Full Text] [Related]
3. Pyrrolopyrimidine lethality in relation to ribonucleic acid synthesis in sarcoma 180 cells in vitro.
Ritch PS; Helmsworth M
Biochem Pharmacol; 1982 Aug; 31(16):2686-8. PubMed ID: 6982713
[No Abstract] [Full Text] [Related]
4. The disposition of the antitumor agent, sangivamycin, in mice.
Hardesty CT; Chaney NA; Waravdekar VS; Mead JA
Cancer Res; 1974 May; 34(5):1005-9. PubMed ID: 4823899
[No Abstract] [Full Text] [Related]
5. Cytokinetic and biochemical effects of sangivamycin in human colon carcinoma cells in culture.
Glazer RI; Hartman KD
Mol Pharmacol; 1981 Nov; 20(3):657-61. PubMed ID: 7329408
[No Abstract] [Full Text] [Related]
6. Effect of sangivamycin and xylosyladenine on the synthesis and methylation of polysomal ribonucleic acid in Ehrlich ascites cells in vitro.
Glazer RI; Hartman KD; Cohen OJ
Biochem Pharmacol; 1981 Oct; 30(19):2697-701. PubMed ID: 7295353
[No Abstract] [Full Text] [Related]
7. Antitumor activity of yunnanmycin. A novel pyrimidine nucleoside antibiotic.
Zhen YS; Qi CQ; Hu JL; Xue YC; Chen WJ
Adv Exp Med Biol; 1998; 431():575-9. PubMed ID: 9598131
[No Abstract] [Full Text] [Related]
8. Kinetic effects of sangivamycin in sarcoma 180 in vitro.
Ritch PS; Glazer RI; Cunningham RE; Shackney SE
Cancer Res; 1981 May; 41(5):1784-8. PubMed ID: 7214345
[TBL] [Abstract][Full Text] [Related]
9. Biochemical effects of the Vinca alkaloids. IV. Studies with vinleurosine.
Creasey WA
Biochem Pharmacol; 1969 Jan; 18(1):227-32. PubMed ID: 5780988
[No Abstract] [Full Text] [Related]
10. Effect of chelating agents upon the synthesis of nucleic acids and protein: inhibition of DNA synthesis by 1-formylisoquinoline thiosemicarbazone.
Sartorelli AC
Biochem Biophys Res Commun; 1967 Apr; 27(1):26-32. PubMed ID: 6048237
[No Abstract] [Full Text] [Related]
11. [Effects of anemodeanin A on DNA, RNA and protein of tumor cells in vitro and plasma cAMP in mice].
Liu LS; Xiao XH; Zhang LD; Zheng RL; Wu FE; Zhu ZQ
Zhongguo Yao Li Xue Bao; 1985 Sep; 6(3):192-4. PubMed ID: 3017045
[No Abstract] [Full Text] [Related]
12. ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC.
Stockwin LH; Yu SX; Stotler H; Hollingshead MG; Newton DL
BMC Cancer; 2009 Feb; 9():63. PubMed ID: 19232100
[TBL] [Abstract][Full Text] [Related]
13. Effect of caffeine on macromolecular synthesis in sarcoma-180 mouse ascites cells.
Chaudhuri MM; Ghosh S
Indian J Exp Biol; 1982 Jun; 20(6):433-6. PubMed ID: 7129540
[No Abstract] [Full Text] [Related]
14. [Estimation of tumor sensitivity in vitro. I. Comparative studies with the Jensen sarcoma in vivo and in vitro after 1-hour-incubation].
Seidel HJ; Wegner LA
Z Krebsforsch; 1969; 72(2):105-18. PubMed ID: 4182038
[No Abstract] [Full Text] [Related]
15. Effect of D-mannosamine on the metabolism of sarcoma 180 ascites cells.
Raisys VA; Winzler RJ
Proc Soc Exp Biol Med; 1971 Dec; 138(3):893-8. PubMed ID: 5131631
[No Abstract] [Full Text] [Related]
16. Correlations between cytotoxicity, biochemical effects, drug levels, and therapeutic effectiveness of daunomycin and adriamycin on Sarcoma 180 ascites in mice.
Silvestrini R; Lenaz L; Di Fronzo G; Sanfilippo O
Cancer Res; 1973 Nov; 33(11):2954-8. PubMed ID: 4748447
[No Abstract] [Full Text] [Related]
17. Inhibition of deoxyribonucleotide synthesis by pyridine carboxaldehyde thiosemicarbazones.
Moore EC; Booth BA; Sartorelli AC
Cancer Res; 1971 Mar; 31(3):235-8. PubMed ID: 5102115
[No Abstract] [Full Text] [Related]
18. Biochemical effects of berberine.
Creasey WA
Biochem Pharmacol; 1979 Apr; 28(7):1081-4. PubMed ID: 444265
[No Abstract] [Full Text] [Related]
19. The antineoplastic and biochemical effects of some 5-fluoropyrimidines.
Sartorelli AC; Creasey WA
Cancer Res; 1967 Nov; 27(11):2201-6. PubMed ID: 6073510
[No Abstract] [Full Text] [Related]
20. In vitro translational activity of messenger RNA following treatment of human colon carcinoma cells with sangivamycin.
Glazer RI; Hartman KD
Mol Pharmacol; 1983 Nov; 24(3):509-12. PubMed ID: 6633511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
